IL1R1 and neoplasm: Thus, RT+IRAK1i-based radiosensitization strategies, whether alone or in combination with TLRa-based IT, would be expected to largely spare IL-1R/TLR-initiated immune attacks on the tumor, leading to an effective “one-two punch” both from within and outside the irradiated tumor (Figure 2C).